Non-small cell lung cancer 2 cm or less: robotic segmentectomy sets the gold standard against non-surgical therapy
- PMID: 31576304
- PMCID: PMC6685859
- DOI: 10.21037/atm.2019.04.51
Non-small cell lung cancer 2 cm or less: robotic segmentectomy sets the gold standard against non-surgical therapy
Conflict of interest statement
Conflicts of Interest: Dr. Ferrari-Light has no disclosures or conflicts of interest to declare. Dr. Cerfolio discloses relationships with Bovie, Community Health Services, Covidien/Medtronic, C-SATS, Davol/Bard, Ethicon, Google/Verb, Intuitive Surgical, KCI/Acelity Company, Myriad Genetics, Pinnacle, ROLO-7 Consulting Firm and TEGO Corporation.
Comment on
-
Long-term results of robotic anatomical segmentectomy for early-stage non-small-cell lung cancer.Eur J Cardiothorac Surg. 2019 Mar 1;55(3):427-433. doi: 10.1093/ejcts/ezy332. Eur J Cardiothorac Surg. 2019. PMID: 30325403
References
Publication types
LinkOut - more resources
Full Text Sources